Randomized trial of phosphodiesterase inhibitors versus catecholamines in patients with acutely decompensated heart failure

Japanese Circulation Journal

Volumn 65, Issue 10, 2001, Pages 858-862

  Kawamura, A ^a   Yoshikawa, T ^a   Takahashi, T ^a   Hayashi, T ^a   Takahashi, E ^a   Anzai, T ^a   Sato, T ^a   Ogawa, S ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENOMEDULLIN; ALDOSTERONE; AMRINONE; ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE DERIVATIVE; CYTOKINE; DOBUTAMINE; DOPAMINE; ENDOTHELIN 1; INTERLEUKIN 6; LOPRINONE; MILRINONE; NEUROHORMONE; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; RENIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CATECHOLAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART OUTPUT; HEMODYNAMIC MONITORING; HORMONE BLOOD LEVEL; HUMAN; LUNG CAPILLARY PRESSURE; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SWAN GANZ CATHETER; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ACUTE DISEASE; BLOOD; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEMODYNAMICS; LUNG WEDGE PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY;

ACUTE DISEASE; AGED; CARDIAC OUTPUT; CATECHOLAMINES; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEUROTRANSMITTER AGENTS; PHOSPHODIESTERASE INHIBITORS; PULMONARY WEDGE PRESSURE;

EID: 0034765666     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.858     Document Type: Article

References (29)

1. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts
2. Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heart
3. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure
4. Plasma norepinephrine as a guide to the prognosis in patients with chronic congestive heart failure
5. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
6. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril
7. Endothelin in human heart failure
8. Attenuation of compensation of endogenous cardiac natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
9. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction
10. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α
11. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α
12. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
13. Effect of amrinone on tumor necrosis factor production in endotoxin shock
14. Amrinone suppresses the synthesis of tumor necrosis factor-α in human mononuclear cells
15. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
16. Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: Interaction with stimulants of adenylyl cyclase
17. Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors
18. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines
19. Differential remodeling of the left and right heart after norepinephrine treatment in rats: Studies on cytokines and collagen
20. Effects of intravenous amrinone on heart failure complicated by acute myocardial infarction: Comparative study with dopamine and dobutamine
21. Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism
22. Comparison of the effects of amrinone, milrinone and olprinone in reversing bupivacaine-induced cardiovascular depression
23. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: Evidence for brain natriuretic peptide as an 'emergency' cardiac hormones against ventricular overload
24. Different secretion patterns of atrial natiuretic peptide and brain natriuretic peptide in patients with congestive heart failure
25. Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression
26. Differential modulation of cytokine production by drugs: Implications for therapy in heart failure
27. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis
28. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
29. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice